Hypoxia-Mediated Signaling Pathways

Handbook of Cell Signaling: Volume 1-3

Volumn 1-3, Issue , 2003, Pages 277-282

  Koong, Albert C ^a   Giaccia, Amato J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3042787848     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012124546-7/50673-2     Document Type: Chapter

References (58)

1. Brizel, D. M. et al. (19xx). Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int. J. Radiat. Oncol. Biol. Phys. 38, 285–289.
2. M. Nordsmark, M. Overgaard and J. Overgaard (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother. Oncol. 41(1), 31-39.
3. D.M. Brizel, et al. (1996) Tumor oxygenation predicts for likelihood of distant metastasis in human soft tissue sarcoma. Cancer Res. 56(5), 941-943.
4. M. Hockel, et al. (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res. 56(19), 4509-4515.
5. J.M. Brown and A.J. Giaccia (1998) The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res. 58(7), 1408-1416.
6. A.L. Harris (2001) Hypoxia—A key regulatory factor in tumor growth. Nat. Rev. Cancer 2(1), 38-47.
7. R.A. Cairns, T. Kalliomaki and R.P. Hill (2001) Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res. 61(24), 8903-8908.
8. T.G. Graeber, et al. (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379(6560), 88-91.
9. K.S. Yao, et al. (1994) Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol. Cell Biol. 14(9), 5999-6003.
10. W.A. Ausserer, et al. (1994) Regulation of c-jun expression during hypoxic and low-glucose stress. Mol. Cell Biol. 14(8), 5032-5042.
11. K.R. Laderoute, et al. (2002) The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent. Mol. Cell Biol. 22(8), 2515-2523.
12. A.C. Koong, E.Y. Chen and A.J. Giaccia (1994) Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of I kappa B alpha on tyrosine residues. Cancer Res. 54(6), 1425-1430.
13. A.C. Koong, et al. (1994) Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Cancer Res. 54(20), 5273-5279.
14. S.K. Bae, et al. (1999) Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia. Cancer Res. 59(23), 5989-5994.
15. H. Nishi, K.H. Nishi and A.C. Johnson (2002) Early Growth Response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res. 62(3), 827-834.
16. H. Matsui, et al. (1999) Induction of interleukin (IL)-6 by hypoxia is mediated by nuclear factor (NF)-kappa B and NF-IL6 in cardiac myocytes. Cardiovasc. Res. 42(1), 104-112.
17. T. Hehlgans, et al. (2001) Hypoxic upregulation of TNF receptor type 2 expression involves NF-IL-6 and is independent of HIF-1 or HIF-2. J. Interferon Cytokine Res. 21(9), 757-762.
18. G.L. Semenza (2001) Hypoxia-inducible factor 1: Oxygen homeostasis and disease pathophysiology. Trends Mol. Med. 7(8), 345-350.
19. H. Zhong, et al. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res. 59(22), 5830-5835.
20. K.L. Talks, et al. (2000) the expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. Am. J. Pathol. 157(2), 411-421.
21. D. Zagzag, et al. (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: Association with angiogenesis, invasion, and progression. Cancer 88(11), 2606-2618.
22. D.M. Aebersold, et al. (2001) Expression of hypoxia-inducible factor-1alpha: A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61(7), 2911-2916.
23. M.A. Goldberg, S.P. Dunning and H.F. Bunn (1988) Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 242(4884), 1412-1415.
24. M.A. Goldberg and T.J. Schneider (1994) Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269(6), 4355-4359.
25. L.E. Huang, et al. (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J. Biol. Chem. 271(50), 32253-32259.
26. A.C. Epstein, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107(1), 43-54.
27. G.L. Wang and G.L. Semenza (1993) Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268(29), 21513-21518.
28. H. Suzuki, A. Tomida and T. Tsuruo (2001) Dephosphorylated hypoxia-inducible factor 1alpha as a mediator of p53-dependent apoptosis during hypoxia. Oncogene 20(41), 5779-5788.
29. J.A. Forsythe, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16(9), 4604-4613.
30. I. Stein, et al. (1998) Translation of vascular endothelial growth factor mRNA by itnernal ribosome entry: Implications for translation under hypoxia. Mol. Cell Biol. 18(6), 3112-3119.
31. I. Huez, et al. (1998) Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA. Mol. Cell Biol. 18(11), 6178-6190.
32. L.C. Cantley and B.G. Neel (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc. Natl. Acad. Sci. USA 96(8), 4240-4245.
33. W. Zundel, et al. (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev. 14(4), 391-396.
34. C. Blancher, et al. (2001) Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3′-kinase/Akt signaling pathway. Cancer Res. 61(19), 7349-7355.
35. E. Laughner, et al. (2001) HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: Novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol. Cell Biol. 21(12), 3995-4004.
36. H. Zhong, et al. (2000) Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res. 60(6), 1541-1545.
37. B.H. Jiang, et al. (2001) Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth Differ. 12(7), 363-369.
38. N.M. Mazure, et al. (1997) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 90(9), 3322-3331.
39. M. Alvarez-Tejado, et al. (2002) Lack of evidence for the involvement of the phosphoinositide 3-kinase/Akt pathway in the activation of hypoxia-inducible factors by low oxygen tension. J. Biol. Chem. 277(16), 13508-13517.
40. D. Mukhopadhyay, et al. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375(6532), 577-581.
41. J.M. Gleadle and P.J. Ratcliffe (1997) Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: Evidence against a regulatory role for Src kinase. Blood 89(2), 503-509.
42. S. Pal, et al. (2001) Central role of p53 on regulation of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in mammary carcinoma. Cancer Res. 61(18), 6952-6957.
43. K.J. Travers, et al. (2000) Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 101(3), 249-258.
44. K. Mori (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101(5), 451-454.
45. Y. Ma and L.M. Hendershot (2001) The unfolding tale of the unfolded protein response. Cell 107(7), 827-830.
46. X.Z. Wang, et al. (1998) Cloning of mammalian Ire1 reveals diversity in the ER stress responses. EMBO J. 17(19), 5708-5717.
47. W. Tirasophon, A.A. Welihinda and R.J. Kaufman (1998) A stress response pathway from the endoplasmic reticulum to the nucleus requires a novel bifunctional protein kinase/endoribonuclease (Ire1p) in mammalian cells. Genes Dev. 12(12), 1812-1824.
48. H. Yoshida, et al. (2001) XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor. Cell 107(7), 881-891.
49. K. Lee, et al. (2002) IRE1-mediated unconventional mRNA splicing and S2P-mediated ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein response. Genes Dev. 16(4), 452-466.
50. H. Yoshida, et al. (1998) Identification of the cis-acting endoplasmic reticulum stress response element responsible for transcriptional induction of mammalian glucose-regulated proteins. Involvement of basic leucine zipper transcription factors. J. Biol. Chem. 273(50), 33741-33749.
51. W.W. Li, et al. (1994) Stress induction of the mammalian GRP78/BiP protein gene: In vivo genomic footprinting and identification of p70CORE from human nuclear extract as a DNA-binding component specific to the stress regulatory element. Mol. Cell Biol. 14(8), 5533-5546.
52. H. Yoshida, et al. (2000) ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Mol. Cell Biol. 20(18), 6755-6767.
53. R. Parker, et al. (2001) Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: Its autoregulation by stress and interaction with ATF6. Mol. Cell Biol. 21(9), 3220-3233.
54. M. Li, et al. (2000) ATF6 as a transcription activator of the endoplasmic reticulum stress element: Thapsigargin stress-induced changes and synergistic interactions with NF-Y and YY1. Mol. Cell Biol. 20(14), 5096-5106.
55. M.S. Song, et al. (2001) Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade. Cancer Res. 61(22), 8322-8330.
56. A.C. Koong, E.A. Auger, E.Y. Chen and A.J. Giaccia (1994) The regulation of GRP78 and messenger RNA levels by hypoxia is modulated by protein kinase C activators and inhibitors. Radiat. Res. 138(1 Suppl.), S60-S63.
57. A.C. Koong, E.Y. Chen, A.S. Lee, J.M. Brown and A.J. Giacci (1994) Increased cytotoxicity of chronic hypoxic cells by molecular inhibition of GRP78 induction. Int. J. Radiat. Oncol. Biol. Phys. 28(3), 661-666.
58. K. Ozawa, et al. (2001) Regulation of tumor angiogenesis by oxygen-regulated protein 150, an inducible endoplasmic reticulum chaperone. Cancer Res. 61(10), 4206-4213.